Overview

A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety, tolerability, and pharmacokinetics of ALKS 8700, a monomethyl fumerate (MMF) molecule.
Phase:
Phase 1
Details
Lead Sponsor:
Alkermes, Inc.
Biogen
Treatments:
Dimethyl Fumarate